Fintel reports that on May 16, 2025, Jones Trading downgraded their outlook for Oncolytics Biotech (NasdaqCM:ONCY) from Buy ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

The new data from PureTech come after the company reported successful results from the phase 2b Elevate study in December ...

The office in Penzberg is CRB's 21st office overall, and its third in Europe -- joining Stuttgart, Germany, and Basel, ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team capabilities as the business progresses ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

President Trump’s science adviser called for a return to reproducible and transparent research to kickstart stalled ...

Quantum computing has been lurking in the background for years. Discover 5 cutting-edge science sectors like CRISPR and ...

Personalized healthcare could lead to a further fragmented system if organizations do not work to introduce and accept ...